Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes

Journal of Investigative Dermatology

Volumn 107, Issue 1, 1996, Pages 88-94

  Travers, Jeffrey B ^a,c   Harrison, Kathleen A ^b   Johnson, Christopher A ^b   Clay, Keith L ^b   Morelli, Joseph G ^a   Murphy, Robert C ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Endothelin; Glycerophospholipids; Intracellular calcium; Mass spectrometry; Molecular species

Indexed keywords

CALCIMYCIN; GLYCEROPHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BIOSYNTHESIS; CALCIUM MOBILIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; MASS SPECTROMETRY; PRIORITY JOURNAL;

EID: 0030062207     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12298295     Document Type: Article

References (47)

1. Albert DH, Snyder F: Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. J Biol Chem 258:97-105, 1983
2. Bagnato A, Venuti A, DiCastro V, Mariante ML: Identification of ETA receptor subtype that mediates endothelin-induced autocrine proliferation of human keratinocytes. Biochim Biophys Res Commun 209:80-86, 1993
3. Barker J, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 337:211-215, 1991
4. 3H)arachidonic acid into molecular species of phospholipid subclasses by cultured human endothelial cells. Biochim Biophys Acta 877:211-215, 1988
5. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-915, 1959
6. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-778, 1988
7. Braquet P, Touqui L, Shen TY, Vargaftig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 39:97-145, 1987
8. Bussolino F, Breviario F, Tetta C, Agglietta M, Mantovani A, Dejana E: Interleukin-1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest 77:2027-2034, 1986
9. Bussolino F, Camussi G, Baglioni C: Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-1-alpha. J Biol Chem 263:11856-11861, 1988
10. Cabre F, Tost D, Suesa N, Gutierez M, Ucedo P, Mauleen D, Carganico G: Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists. Agents Actions 38:212-219, 1993
11. Chilton FH, Ellis JM, Olson S, Wykle RL: 1-O-Alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem 259:12014-12020, 1984
12. Clay KL: Quantitation of platelet-activating factor by gas chromatography-mass spectrometry. Methods Enzymol 187:134-147, 1990
13. Clay KL, Johnson C, Worthen GS: Biosynthesis of platelet-activating factor and 1-O-acyl analogues by endothelial cells. Biochim Biophys Acta 1094:43-50, 1991
14. Clay KL, Murphy RC, Andres JL, Lynch J, Henson PM: Structure elucidation of platelet-activating factor derived from human neutrophils. Biochim Biophys Res Commun 121:815-825, 1984
15. Kayganich K, Murphy RC: Fast atom bombardment tandem mass spectrometric identification of diacyl, alkyl-acyl, and alk-1-enyl acyl molecular species of glycerophosphoethanolamine in human neutrophils. Anal Chem 64:2965-2971, 1992
16. Kupper TS, Ballard DW, Chua AO, McGuire JS, Flood PM, Horowitz MC, Langdon R, Lightfoot L, Gubler U: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1-alpha and beta mRNA. J Exp Med 164:2095-2104, 1986
17. Leprince C, Vivier E, Treton D, Galanaud P, Benveniste J, Richard Y, Thomas Y: Immunoregulatory functions of PAF-acether. VI, Dual effect on human B cell proliferation. Lipids 26:1204-1208, 1991
18. Levesque JP, Hatzfeld A, Hatzfeld J: Fibrinogen mitogenic effect on hemopoetic cell lines: control via receptor modulation. Proc Natl Acad Sci USA 83:6494-6498, 1986
19. Luger TA, Schwarz T: Epidermal-derived cytokines. In Skin Immune System. Bos JD (ed.), CRC, Boca Raton, FL, 1990, Chap. 14, pp 257-291
20. Lynch JM, Henson PM: The intracellular retention of newly synthesized platelet-activating factor. J Immunol 137:2653-2661, 1986
21. Marcelo CL, Duell EA, Rhodes LM, Dunham WR: An in vitro model of essential fatty acid deficiency. J Invest Dermatol 99:703-708, 1992
22. McIntyre TM, Zimmerman GA, Satoh K, Prescott SN: Cultured endothelial cell synthesize both platelet-activating factor and prostcyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 76:271-281, 1985
23. Michel L, Denizot Y, Thomas Y, Jean-Louis F, Heslan M, Benveniste J, Dubertret L: Production of PAF-acether by human epidermal cells. J Invest Dermatol 95:576-581, 1990
24. Michel L, Denizot Y, Thomas Y, Jean-Louis F, Pitton C, Benveniste J, Dubertret I: Biosynthesis of Paf-acether by human skin fibroblasts in vitro. J Immunol 141:948-954, 1988
25. Montero A, Rodriguez-Barbero A, Lopez-Novoa JM: A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. Eur J Pharmacol 243:235-240, 1993
26. Mueller HW, O'Flaherty JT, Wykle RL: The molecular species distribution of platelet-activating factor synthesized by rabbit and human neutrophils. J Biol Chem 259:14554-14561, 1984
27. Mustafa, SB, Gandhi CR, Harvey SA, Olson MS: Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology 21:545-553, 1995
28. Pignol B, Lonchampt MO, Mencia-Huerta JM, Braquet P: Platelet-activating factor potentiates interleukin-1/epidermal cell derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide. J Lipid Mediat 2(suppl):S83-S91, 1990
29. Prescott SM, Zimmerman GA, McIntyre TM: Platelet-activating factor. J Biol Chem 265:17381-17384, 1990
30. Stoll LL, Figard PH, Yerram NR, Yorek MA, Spector AA: 1-O-Alkyl-2-acetyl glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells. Cell Regul 1:13-25, 1989
31. Tessner TG, O'Flaherty JT, Wykle RL: Stimulation of platelet-activating factor biosynthesis by a non-metabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem 264:4794-4800, 1989
32. Travers JB, Huff JC, Rola-Pleszczynski M, Gelfand EW, Morelli JG, Murphy RC. Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816-823, 1995
33. Triggiani M, Fonteh AN, Chilton FH: Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. Biochem J 286:497-503, 1992
34. Triggiani M, Goldman DW, Chilton FH: Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochim Biophys Acta 1084: 41-49, 1991a
35. Triggiani M, Schleimer RP, Warner JA, Chilton FH: Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol 147:660-667, 1991b
36. Tokumura A, Takauchi K, Asai T, Kamiyasu K, Ogawa H, Tsukatani, T: Novel molecular analogues of phosphocholine in a lipid extract from bovine brain 1-long-chain acyl-2-short chain acyl-sn-glycero-3-phosphocholine. J Lipid Res 30:219-227, 1989
37. Tordai A, Franklin R, Johnson C, Mazer BD, Clay KL, Gelfand, EW: Autocrine stimulation of B lymphocytes by a platelet-activating factor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine. J Immunol 152:566-573, 1994
38. Tsuboi R, Sato C, Shi CM, Nakamora T, Sakurai T, Ogawa H: Endothelin-1 acts as an autocrine growth factor for normal human keratinocytes. J Cell Physiol 159:213-220, 1994
39. Valone FH, Epstein LB: Biphasic platelet-activating factor synthesis by human monocytes stimulated with II-1 beta, tumor necrosis factor, or interferon-gamma. J Immunol 141:3945-3951, 1988
40. 3H)alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils. J Biol Chem 266:18691-96, 1991
41. Wardlow ML, Cox CP, Meng KE, Greene DE, Farr RS: Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor. J Immunol 136:3441-48, 1986
42. Weintraub ST, Ludwig JC, Mott GE, McManus LM, Lear C, Pinckard RN: Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Biochem Biophys Res Commun 129:868-876, 1985
43. Wheelan P, Clay KL: Albumin and fatty acid effects on the stimulated production of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) by human polymorphonuclear leukocytes. Biochim Biophys Acta 1127:284-292, 1992
44. Winkler JD, Sung C, Hubbard WC, Chilton FH: Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils. Biochem Pharmacol 44:2055-60, 1992
45. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-489, 1992
46. Yohn JJ, Morelli JG, Walchak SJ, Rundell KB, Norris DA, Zamora MR: Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 100:23-26, 1993
47. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM: Endothelial cell-associated platelet-activating factor: a novel mechanism for signal intracellular adhesion. J Cell Biol 110:529-540, 1990